Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,526Revenue $M443Net Margin (%)59.7Z-Score4.1
Enterprise Value $M1,711EPS $1.7Operating Margin %92.0F-Score4
P/E(ttm))5.4Cash Flow Per Share $1.5Pre-tax Margin (%)90.7Higher ROA y-yN
Price/Book7.610-y EBITDA Growth Rate %0Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %20.0Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow5.0y-y EBITDA Growth Rate %16.2ROA % (ttm)48.6Higher Current Ratio y-yN
Dividend Yield %6.3Insider Buy (3m)0ROE % (ttm)233Less Shares Outstanding y-yN
Payout Ratio %34.0Shares Outstanding M161ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 9.511%Reduce -50.19%1,665,543
PDLIJohn Hussman 2013-12-31 Reduce-0.49%$7.59 - $10.1
($8.43)
$ 9.513%Reduce -50.99%1,087,000
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 9.518%Add 24.84%2,890,564
PDLIJohn Hussman 2013-09-30 Reduce-0.21%$7.72 - $8.44
($8.04)
$ 9.518%Reduce -21.04%2,218,000
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 9.534%Add 23.5%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 9.523%Add 561.89%1,729,133
PDLIJohn Hussman 2012-12-31 Add0.09%$7.09 - $8.37
($7.75)
$ 9.523%Add 20.19%3,012,000
PDLIJohn Hussman 2012-09-30 Add0.29%$6.59 - $7.73
($7.11)
$ 9.534%Add 176.91%2,506,000
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 9.560%Add 33.54%270,346
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 9.560%Sold Out0
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 9.559%Add 31.29%202,444
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 9.559%Reduce -48.84%8,000,000
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 9.559%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 9.561%Add 68.81%15,636,000
PDLIJohn Hussman 2011-09-30 Buy 0.08%$5.47 - $6.39
($5.91)
$ 9.561%New holding, 905000 sh.905,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 9.561%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 9.561%New holding, 10000 sh.10,000
PDLIGeorge Soros 2011-06-30 Sold Out $5.74 - $6.64
($6.23)
$ 9.552%Sold Out0
PDLISeth Klarman 2011-03-31 Add1.6%$4.69 - $6.36
($5.38)
$ 9.577%Add 87.3%10,495,225
PDLIJoel Greenblatt 2011-03-31 Add0.12%$4.69 - $6.36
($5.38)
$ 9.577%Add 128.09%126,863
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PDLI John Hussman 2014-03-311,087,0000.680.68
PDLI Jean-Marie Eveillard 2014-03-312,80000
PDLI Joel Greenblatt 2014-03-311,665,5431.040.21-50.19%
Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lindell Jody SDirector 2011-03-15Buy374$5.3378.24view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7166.37view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1853.72view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.3314.05view
Lindell Jody SDirector 2009-06-15Buy3,000$7.7622.42view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.3828.73view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.3828.73view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.50view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-1.04view
KLEIN JOSEPH IIIDirector 2008-04-21Buy500$13.87-31.51view

Press Releases about PDLI :

    Quarterly/Annual Reports about PDLI:

    News about PDLI:

    Articles On GuruFocus.com
    Hot Picks with High Yields Jul 23 2013 
    My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
    comment on PDLI May 12 2013 
    My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
    FV 22 MSN 10 Apr 19 2013 
    68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
    20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
    comment on PDLI Nov 13 2012 
    Seth Klarman’s Investment Framework Sep 15 2012 
    A Look at Two Undervalued Small-Cap Health Care Stocks Aug 09 2012 

    More From Other Websites
    Best High-Yielding Stocks According To Greenblatt Principles: PDL BioPharma Jul 11 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 07 2014
    PDL BioPharma to Participate in Upcoming Investor Conferences Jun 24 2014
    PDL BioPharma: Panning For Dividend Gold Jun 13 2014
    PDL BioPharma Completes Regular Quarterly Dividend Payment Jun 12 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 12 2014
    PDL BioPharma Views Lower Q2 Revenues Jun 11 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 10 2014
    PDL BioPharma Provides Second Quarter 2014 Revenue Guidance of $140 Million Jun 10 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 05 2014
    PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Jun 04 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 04 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of... May 30 2014
    PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference May 29 2014
    Lightning Round: Sodastream, Amazon & more May 21 2014
    PDL BioPharma: Bringing In Assets, Generous Dividend And Cheap Valuations Add To Upside May 21 2014
    PDL BIOPHARMA, INC. Financials May 20 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide